Accessibility settings

Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/76628, first published .
Frailty Trajectories and Influencing Factors in Patients With Non-Hodgkin Lymphoma During Chemotherapy: Protocol for a Longitudinal Mixed Methods Study

Frailty Trajectories and Influencing Factors in Patients With Non-Hodgkin Lymphoma During Chemotherapy: Protocol for a Longitudinal Mixed Methods Study

Frailty Trajectories and Influencing Factors in Patients With Non-Hodgkin Lymphoma During Chemotherapy: Protocol for a Longitudinal Mixed Methods Study

Journals

  1. Cornago J, Baile M, Acera M, Fox L, del Mar Pérez‐Artigas M, Santamaría A, del Carmen Quintela M, Sánchez‐Salinas A, Salmerón J, Illana V, Abdallahi‐Lefdil Z, Pardo L, Solán L, López‐Lorenzo J, Fernández‐Luis S, Vega L, Villar S, Beorlegui‐Murillo P, Molina M, Esquirol A, Izquierdo I, Ribes J, Mussetti A, Lavilla E, Alda O, López‐Marín J, Bento L, Filaferro S, Balsalobre P, Sureda A, Salas M. Prospective implementation of the HCT frailty scale in adults with lymphoproliferative syndromes candidates for autologous haematopoietic stem cell transplantation: Results from a multicentre GETH‐TC study. British Journal of Haematology 2026 View